NEW YORK (GenomeWeb) – Nanosphere today announced after the close of the market that its first quarter revenues rose 41 percent on sales of its Verigene Gram Positive and Gram Negative Blood Culture Tests.

The firm also said that it has entered into a definitive agreement with an institutional investor in a registered direct offering of $4.4 million and entered into a new $30 million debt facility with NSPH Funding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.